Results 1 to 10 of about 3,769,586 (361)

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Nature, 2022
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.2.12.1, BA.4 and BA.5 exhibit higher transmissibility than the BA.2 lineage1.
Yunlong Cao, Fanchong Jian, Shuo Du
exaly   +2 more sources

Potently neutralizing and protective human antibodies against SARS-CoV-2

Nature, 2020
The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health1 and the medical countermeasures available so far are limited2,3.
Elaine C Chen, James J Steinhardt, Abishek Chandrashekar   +2 more
exaly   +2 more sources

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Nature, 2021
Jianliang Xu, Justin Dasilva, Sébastien Poncet   +2 more
exaly   +2 more sources

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Nature, 2020
Jinfang Yu, Jincun Zhao, Jiwan Ge
exaly   +2 more sources

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Nature, 2020
David D Ho, Manoj S Nair, Yaoxing Huang
exaly   +2 more sources

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

Nature, 2021
The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies requires immediate investigation.
Yunlong Cao, Jing Wang, F. Jian, T. Xiao, Weiliang Song, A. Yisimayi, Weijing Huang, Qian-qian Li, Peng Wang, R. An, Jing Wang, Yao Wang, Xiaowei Niu, Sijie Yang, Huitong Liang, Haiyan Sun, Taojing Li, Yuanling Yu, Qianqian Cui, Shuo Liu, Xiaodong Yang, Shuo Du, Zhiying Zhang, Xiaohua Hao, Fei Shao, R. Jin, Xiangxi Wang, Junyu Xiao, Youchun Wang, X. Xie   +29 more
semanticscholar   +1 more source

Acknowledgment to the Reviewers of Antibodies in 2022

Antibodies, 2023
High-quality academic publishing is built on rigorous peer review [...]
Antibodies Editorial Office
doaj   +1 more source

Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies

bioRxiv, 2021
The evolution of SARS-CoV-2 could impair recognition of the virus by human antibody-mediated immunity. To facilitate prospective surveillance for such evolution, we map how convalescent serum antibodies are impacted by all mutations to the spike’s ...
Allison J. Greaney, Andrea N. Loes, K. H. Crawford, Tyler N. Starr, Keara D. Malone, H. Chu, J. Bloom   +6 more
semanticscholar   +1 more source

Acknowledgment to Reviewers of Antibodies in 2021

Antibodies, 2022
Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Antibodies Editorial Office
doaj   +1 more source

Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

New England Journal of Medicine, 2020
Coagulopathy in Critical Illness with Covid-19 The authors describe a 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covid-19 who were also seen in the same intensive care unit ...
Yan Zhang, M. Xiao, Shulan Zhang, P. Xia, W. Cao, Wei Jiang, Huan Chen, X. Ding, Hua Zhao, Hongmin Zhang, Chun-yao Wang, Jing Zhao, Xuefeng Sun, R. Tian, Wei Wu, Dong Wu, Jie Ma, Yu Chen, D. Zhang, Jing Xie, Xiaowei Yan, Xiang Zhou, Zheng-yin Liu, Jinglan Wang, B. Du, Yan Qin, P. Gao, X. Qin, Yingchun Xu, Wen Zhang, Taisheng Li, Fengchun Zhang, Yongqiang Zhao, Yongzhe Li, Shuyang Zhang   +34 more
semanticscholar   +1 more source